|
|
Symposium 56 - A Historical Perspective and Modern Techniques in Pulmonary Pathology
Thursday, September 21, 2006 08:00 - 12:00
|
|
Moderators:
|
Dr. Henry D. Tazelaar, Dr. Ming S. Tsao and Dr. Brendan Mullen
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Wilbur Franklin indicated is has grant/research support from Eli Lilly and Astrazeneca. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click any blue section number below to display text and references for individual lectures:
| Antiquity to Liebow- Milestones in Pulmonary Pathology
David Dail |
| A Saga of Acute Lung Injury: Diffuse Alveolar Damage (DAD) – Past, Present, and Future
Joseph F. Tomashefski, Jr. |
| Curing Idiopathic Pulmonary Fibrosis: Beyond Interferon Gamma
Kevin O. Leslie |
| Targeted Therapies for Lung Cancer - EGFR Inhibitors
Wilbur A. Franklin |
| Contributions of Gene Expression Profiling to the Diagnosis and Classification of Mesothelioma and Lung Cancer
Marc Ladanyi |
| Applications of Microdissection Techniques in Pulmonary Pathology
Diana N. Ionescu |
|
|
|
|
